Cargando…
Mechanisms of Ovarian Cancer Metastasis: Biochemical Pathways
Ovarian cancer is the most lethal gynecologic malignancy. Despite advances in chemotherapy, the five-year survival rate of advanced ovarian cancer patients with peritoneal metastasis remains around 30%. The most significant prognostic factor is stage, and most patients present at an advanced stage w...
Autores principales: | Nakayama, Kentaro, Nakayama, Naomi, Katagiri, Hiroshi, Miyazaki, Kohji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472771/ https://www.ncbi.nlm.nih.gov/pubmed/23109879 http://dx.doi.org/10.3390/ijms130911705 |
Ejemplares similares
-
KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas
por: Rahman, Mohammed Tanjimur, et al.
Publicado: (2013) -
Endometrial Serous Carcinoma: Its Molecular Characteristics and Histology-Specific Treatment Strategies
por: Nakayama, Kentaro, et al.
Publicado: (2012) -
A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted Therapies
por: Rahman, Munmun, et al.
Publicado: (2013) -
Microwave endometrial ablation as an alternative to hysterectomy for the emergent control of uterine bleeding in patients who are poor surgical candidates
por: Yeasmin, Shamima, et al.
Publicado: (2008) -
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer
por: Nakayama, N, et al.
Publicado: (2008)